ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neoantigen Targeted Therapies Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-38B13139
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Neoantigen Targeted Therapies Market Research Report 2023
BUY CHAPTERS

Global Neoantigen Targeted Therapies Market Insights, Forecast to 2030

Code: QYRE-Auto-38B13139
Report
December 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bavarian Nordic
Genocea Biosciences
Gradalis Inc
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene AG
Neon Therapeutics

Neoantigen Targeted Therapies Market

Recent developments in genomic analysis and advances in bioinformatics have enabled the adoption of more personalized treatment approaches, such as neoantigen targeted therapies. Cancer neoantigens is a term used to refer to a subset of antigens encoded by tumor-specific, mutated genes, which have not previously been recognized by the host’s immune system.
Market Analysis and Insights: Global Neoantigen Targeted Therapies Market
The global Neoantigen Targeted Therapies market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Neoantigen Targeted Therapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Neoantigen Targeted Therapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Neoantigen Targeted Therapies is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Neoantigen Targeted Therapies include Bavarian Nordic, Genocea Biosciences, Gradalis, Immunicum, Immunovative Therapies, Iovance Biotherapeutics, MediGene and Neon Therapeutics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Neoantigen Targeted Therapies is widely used in various fields, such as Medical Research Institution, Hospital and Clinic and Other,, etc. Medical Research Institution provides greatest supports to the Neoantigen Targeted Therapies industry development. In 2023, global % revenue of Neoantigen Targeted Therapies went into Medical Research Institution filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Neoantigen Targeted Therapies market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neoantigen Targeted Therapies, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Neoantigen Targeted Therapies, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neoantigen Targeted Therapies revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Neoantigen Targeted Therapies market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neoantigen Targeted Therapies revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Neoantigen Targeted Therapies Market Report

Report Metric Details
Report Name Neoantigen Targeted Therapies Market
Segment by Type
Segment by Application
  • Medical Research Institution
  • Hospital and Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bavarian Nordic, Genocea Biosciences, Gradalis, Immunicum, Immunovative Therapies, Iovance Biotherapeutics, MediGene, Neon Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Neoantigen Targeted Therapies in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Neoantigen Targeted Therapies companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neoantigen Targeted Therapies revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Neoantigen Targeted Therapies Market report?

Ans: The main players in the Neoantigen Targeted Therapies Market are Bavarian Nordic, Genocea Biosciences, Gradalis, Immunicum, Immunovative Therapies, Iovance Biotherapeutics, MediGene, Neon Therapeutics

What are the Application segmentation covered in the Neoantigen Targeted Therapies Market report?

Ans: The Applications covered in the Neoantigen Targeted Therapies Market report are Medical Research Institution, Hospital and Clinic, Other

What are the Type segmentation covered in the Neoantigen Targeted Therapies Market report?

Ans: The Types covered in the Neoantigen Targeted Therapies Market report are Monotherapy, Combination Therapy

Recommended Reports

Immunotherapy & Cancer

Targeted & Gene Therapy

Advanced Oncology Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neoantigen Targeted Therapies Market Perspective (2019-2030)
2.2 Global Neoantigen Targeted Therapies Growth Trends by Region
2.2.1 Neoantigen Targeted Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Neoantigen Targeted Therapies Historic Market Size by Region (2019-2024)
2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Region (2025-2030)
2.3 Neoantigen Targeted Therapies Market Dynamics
2.3.1 Neoantigen Targeted Therapies Industry Trends
2.3.2 Neoantigen Targeted Therapies Market Drivers
2.3.3 Neoantigen Targeted Therapies Market Challenges
2.3.4 Neoantigen Targeted Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Neoantigen Targeted Therapies by Players
3.1.1 Global Neoantigen Targeted Therapies Revenue by Players (2019-2024)
3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Neoantigen Targeted Therapies, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2023
3.5 Global Key Players of Neoantigen Targeted Therapies Head office and Area Served
3.6 Global Key Players of Neoantigen Targeted Therapies, Product and Application
3.7 Global Key Players of Neoantigen Targeted Therapies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neoantigen Targeted Therapies Breakdown Data by Type
4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2019-2024)
4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2025-2030)
5 Neoantigen Targeted Therapies Breakdown Data by Application
5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2019-2024)
5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Neoantigen Targeted Therapies Market Size (2019-2030)
6.2 North America Neoantigen Targeted Therapies Market Size by Type
6.2.1 North America Neoantigen Targeted Therapies Market Size by Type (2019-2024)
6.2.2 North America Neoantigen Targeted Therapies Market Size by Type (2025-2030)
6.2.3 North America Neoantigen Targeted Therapies Market Share by Type (2019-2030)
6.3 North America Neoantigen Targeted Therapies Market Size by Application
6.3.1 North America Neoantigen Targeted Therapies Market Size by Application (2019-2024)
6.3.2 North America Neoantigen Targeted Therapies Market Size by Application (2025-2030)
6.3.3 North America Neoantigen Targeted Therapies Market Share by Application (2019-2030)
6.4 North America Neoantigen Targeted Therapies Market Size by Country
6.4.1 North America Neoantigen Targeted Therapies Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Neoantigen Targeted Therapies Market Size by Country (2019-2024)
6.4.3 North America Neoantigen Targeted Therapies Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Neoantigen Targeted Therapies Market Size (2019-2030)
7.2 Europe Neoantigen Targeted Therapies Market Size by Type
7.2.1 Europe Neoantigen Targeted Therapies Market Size by Type (2019-2024)
7.2.2 Europe Neoantigen Targeted Therapies Market Size by Type (2025-2030)
7.2.3 Europe Neoantigen Targeted Therapies Market Share by Type (2019-2030)
7.3 Europe Neoantigen Targeted Therapies Market Size by Application
7.3.1 Europe Neoantigen Targeted Therapies Market Size by Application (2019-2024)
7.3.2 Europe Neoantigen Targeted Therapies Market Size by Application (2025-2030)
7.3.3 Europe Neoantigen Targeted Therapies Market Share by Application (2019-2030)
7.4 Europe Neoantigen Targeted Therapies Market Size by Country
7.4.1 Europe Neoantigen Targeted Therapies Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Neoantigen Targeted Therapies Market Size by Country (2019-2024)
7.4.3 Europe Neoantigen Targeted Therapies Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Neoantigen Targeted Therapies Market Size (2019-2030)
8.2 China Neoantigen Targeted Therapies Market Size by Type
8.2.1 China Neoantigen Targeted Therapies Market Size by Type (2019-2024)
8.2.2 China Neoantigen Targeted Therapies Market Size by Type (2025-2030)
8.2.3 China Neoantigen Targeted Therapies Market Share by Type (2019-2030)
8.3 China Neoantigen Targeted Therapies Market Size by Application
8.3.1 China Neoantigen Targeted Therapies Market Size by Application (2019-2024)
8.3.2 China Neoantigen Targeted Therapies Market Size by Application (2025-2030)
8.3.3 China Neoantigen Targeted Therapies Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Neoantigen Targeted Therapies Market Size (2019-2030)
9.2 Asia Neoantigen Targeted Therapies Market Size by Type
9.2.1 Asia Neoantigen Targeted Therapies Market Size by Type (2019-2024)
9.2.2 Asia Neoantigen Targeted Therapies Market Size by Type (2025-2030)
9.2.3 Asia Neoantigen Targeted Therapies Market Share by Type (2019-2030)
9.3 Asia Neoantigen Targeted Therapies Market Size by Application
9.3.1 Asia Neoantigen Targeted Therapies Market Size by Application (2019-2024)
9.3.2 Asia Neoantigen Targeted Therapies Market Size by Application (2025-2030)
9.3.3 Asia Neoantigen Targeted Therapies Market Share by Application (2019-2030)
9.4 Asia Neoantigen Targeted Therapies Market Size by Region
9.4.1 Asia Neoantigen Targeted Therapies Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Neoantigen Targeted Therapies Market Size by Region (2019-2024)
9.4.3 Asia Neoantigen Targeted Therapies Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Type
10.2.1 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Application
10.3.1 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country
10.4.1 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.1.5 Bavarian Nordic Recent Developments
11.2 Genocea Biosciences
11.2.1 Genocea Biosciences Company Details
11.2.2 Genocea Biosciences Business Overview
11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.2.5 Genocea Biosciences Recent Developments
11.3 Gradalis
11.3.1 Gradalis Company Details
11.3.2 Gradalis Business Overview
11.3.3 Gradalis Neoantigen Targeted Therapies Introduction
11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.3.5 Gradalis Recent Developments
11.4 Immunicum
11.4.1 Immunicum Company Details
11.4.2 Immunicum Business Overview
11.4.3 Immunicum Neoantigen Targeted Therapies Introduction
11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.4.5 Immunicum Recent Developments
11.5 Immunovative Therapies
11.5.1 Immunovative Therapies Company Details
11.5.2 Immunovative Therapies Business Overview
11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.5.5 Immunovative Therapies Recent Developments
11.6 Iovance Biotherapeutics
11.6.1 Iovance Biotherapeutics Company Details
11.6.2 Iovance Biotherapeutics Business Overview
11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.6.5 Iovance Biotherapeutics Recent Developments
11.7 MediGene
11.7.1 MediGene Company Details
11.7.2 MediGene Business Overview
11.7.3 MediGene Neoantigen Targeted Therapies Introduction
11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.7.5 MediGene Recent Developments
11.8 Neon Therapeutics
11.8.1 Neon Therapeutics Company Details
11.8.2 Neon Therapeutics Business Overview
11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024)
11.8.5 Neon Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Bavarian Nordic
Genocea Biosciences
Gradalis Inc
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene AG
Neon Therapeutics
List of Tables
    Table 1. Global Neoantigen Targeted Therapies Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Neoantigen Targeted Therapies Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Neoantigen Targeted Therapies Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Neoantigen Targeted Therapies Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Neoantigen Targeted Therapies Market Share by Region (2019-2024)
    Table 8. Global Neoantigen Targeted Therapies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Neoantigen Targeted Therapies Market Share by Region (2025-2030)
    Table 10. Neoantigen Targeted Therapies Market Trends
    Table 11. Neoantigen Targeted Therapies Market Drivers
    Table 12. Neoantigen Targeted Therapies Market Challenges
    Table 13. Neoantigen Targeted Therapies Market Restraints
    Table 14. Global Neoantigen Targeted Therapies Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Neoantigen Targeted Therapies Revenue Share by Players (2019-2024)
    Table 16. Global Top Neoantigen Targeted Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapies as of 2023)
    Table 17. Global Neoantigen Targeted Therapies Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapies Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Neoantigen Targeted Therapies, Headquarters and Area Served
    Table 20. Global Key Players of Neoantigen Targeted Therapies, Product and Application
    Table 21. Global Key Players of Neoantigen Targeted Therapies, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2019-2024)
    Table 25. Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2025-2030)
    Table 27. Global Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Neoantigen Targeted Therapies Revenue Share by Application (2019-2024)
    Table 29. Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Neoantigen Targeted Therapies Revenue Share by Application (2025-2030)
    Table 31. North America Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Neoantigen Targeted Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Neoantigen Targeted Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Neoantigen Targeted Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Neoantigen Targeted Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Neoantigen Targeted Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Neoantigen Targeted Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Neoantigen Targeted Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Neoantigen Targeted Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Neoantigen Targeted Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Neoantigen Targeted Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Neoantigen Targeted Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Neoantigen Targeted Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Neoantigen Targeted Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Neoantigen Targeted Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Neoantigen Targeted Therapies Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Neoantigen Targeted Therapies Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Neoantigen Targeted Therapies Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Bavarian Nordic Company Details
    Table 64. Bavarian Nordic Business Overview
    Table 65. Bavarian Nordic Neoantigen Targeted Therapies Product
    Table 66. Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 67. Bavarian Nordic Recent Developments
    Table 68. Genocea Biosciences Company Details
    Table 69. Genocea Biosciences Business Overview
    Table 70. Genocea Biosciences Neoantigen Targeted Therapies Product
    Table 71. Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 72. Genocea Biosciences Recent Developments
    Table 73. Gradalis Company Details
    Table 74. Gradalis Business Overview
    Table 75. Gradalis Neoantigen Targeted Therapies Product
    Table 76. Gradalis Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 77. Gradalis Recent Developments
    Table 78. Immunicum Company Details
    Table 79. Immunicum Business Overview
    Table 80. Immunicum Neoantigen Targeted Therapies Product
    Table 81. Immunicum Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 82. Immunicum Recent Developments
    Table 83. Immunovative Therapies Company Details
    Table 84. Immunovative Therapies Business Overview
    Table 85. Immunovative Therapies Neoantigen Targeted Therapies Product
    Table 86. Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 87. Immunovative Therapies Recent Developments
    Table 88. Iovance Biotherapeutics Company Details
    Table 89. Iovance Biotherapeutics Business Overview
    Table 90. Iovance Biotherapeutics Neoantigen Targeted Therapies Product
    Table 91. Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 92. Iovance Biotherapeutics Recent Developments
    Table 93. MediGene Company Details
    Table 94. MediGene Business Overview
    Table 95. MediGene Neoantigen Targeted Therapies Product
    Table 96. MediGene Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 97. MediGene Recent Developments
    Table 98. Neon Therapeutics Company Details
    Table 99. Neon Therapeutics Business Overview
    Table 100. Neon Therapeutics Neoantigen Targeted Therapies Product
    Table 101. Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2019-2024) & (US$ Million)
    Table 102. Neon Therapeutics Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neoantigen Targeted Therapies Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Neoantigen Targeted Therapies Market Share by Type: 2023 VS 2030
    Figure 3. Monotherapy Features
    Figure 4. Combination Therapy Features
    Figure 5. Global Neoantigen Targeted Therapies Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Neoantigen Targeted Therapies Market Share by Application: 2023 VS 2030
    Figure 7. Medical Research Institution Case Studies
    Figure 8. Hospital and Clinic Case Studies
    Figure 9. Other Case Studies
    Figure 10. Neoantigen Targeted Therapies Report Years Considered
    Figure 11. Global Neoantigen Targeted Therapies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Neoantigen Targeted Therapies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Neoantigen Targeted Therapies Market Share by Region: 2023 VS 2030
    Figure 14. Global Neoantigen Targeted Therapies Market Share by Players in 2023
    Figure 15. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neoantigen Targeted Therapies as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapies Revenue in 2023
    Figure 17. North America Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Neoantigen Targeted Therapies Market Share by Type (2019-2030)
    Figure 19. North America Neoantigen Targeted Therapies Market Share by Application (2019-2030)
    Figure 20. North America Neoantigen Targeted Therapies Market Share by Country (2019-2030)
    Figure 21. United States Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Neoantigen Targeted Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Neoantigen Targeted Therapies Market Share by Type (2019-2030)
    Figure 25. Europe Neoantigen Targeted Therapies Market Share by Application (2019-2030)
    Figure 26. Europe Neoantigen Targeted Therapies Market Share by Country (2019-2030)
    Figure 27. Germany Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Neoantigen Targeted Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Neoantigen Targeted Therapies Market Share by Type (2019-2030)
    Figure 35. China Neoantigen Targeted Therapies Market Share by Application (2019-2030)
    Figure 36. Asia Neoantigen Targeted Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Neoantigen Targeted Therapies Market Share by Type (2019-2030)
    Figure 38. Asia Neoantigen Targeted Therapies Market Share by Application (2019-2030)
    Figure 39. Asia Neoantigen Targeted Therapies Market Share by Region (2019-2030)
    Figure 40. Japan Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Neoantigen Targeted Therapies Market Share by Country (2019-2030)
    Figure 50. Brazil Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Neoantigen Targeted Therapies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Bavarian Nordic Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 57. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 58. Gradalis Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 59. Immunicum Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 60. Immunovative Therapies Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 61. Iovance Biotherapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 62. MediGene Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 63. Neon Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Neoantigen Targeted Therapy Market Research Report 2024
Global Personalized Cancer Medicine Market Research Report 2025
Global Targeted Cancer Therapy Market Research Report 2024
Neoantigen Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno oncology Therapy Market Insights Forecast to 2030
Global Oncology Targeted Therapy Market Research Report 2025
Global Cancer Biotherapy Market Insights Forecast to 2030
Global Targeted Oncology Drugs Market Research Report 2024
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Personalized Cell Therapy Market Research Report 2024
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Cancer Immunotherapies Market Insights Forecast to 2030
Global Cancer Targeted Drug Market Research Report 2025
Global Cancer Immunotherapy Market Insights Forecast to 2030
Global Targeted Small Molecule Drug Market Research Report 2025
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Global Injectable Targeted Therapy Market Research Report 2024
Global Anti PD 1 MAb Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions